Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ectoin® Inhalation Solution EIL07 as Supportive Treatment for Children and Adult With Mild to Moderate Asthma: a Post-Market Clinical Follow-up (PMCF) Study.

NCT05699941 is registered in ClinicalTrials.gov with Bitop AG as lead sponsor.

NCT NCT05699941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05699941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ectoin® Inhalation Solution EIL07 as Supportive Treatment for Children and Adult With Mild to Moderate Asthma: a Post-Market Clinical Follow-up (PMCF) Study.
Lead sponsor
Bitop AG
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2023
Completion date
October 25, 2023
Enrollment
204 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

asthma